Cargando…
DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T‐cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients
Extranodal natural killer/T‐cell lymphoma, nasal type (ENKL) is a rare peripheral T‐cell lymphoma that predominantly occurs in Asian and South American populations. The treatment of ENKL has been a challenge for a long time. This study was conducted to compare the clinical efficacy and safety of cis...
Autores principales: | Wang, Xin, Hu, Junxia, Dong, Meng, Ding, Mengjie, Zhu, Linan, Wu, Jingjing, Sun, Zhenchang, Li, Xin, Zhang, Lei, Li, Ling, Wang, Xinhua, Fu, Xiaorui, Wang, Guannan, Chen, Qingjiang, Zhang, Mingzhi, Zhang, Xudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877828/ https://www.ncbi.nlm.nih.gov/pubmed/33045134 http://dx.doi.org/10.1111/cts.12893 |
Ejemplares similares
-
The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type
por: Zhang, Lei, et al.
Publicado: (2016) -
Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149
por: Zhang, Lei, et al.
Publicado: (2016) -
Characteristics and Clinical Implications of the Nasal Microbiota in Extranodal NK/T-Cell Lymphoma, Nasal Type
por: Shi, Zhuangzhuang, et al.
Publicado: (2021) -
Combined use of DDGP and IMRT has a good effect on extranodal natural killer/T‐cell lymphoma, nasal type
por: Zheng, Yingjuan, et al.
Publicado: (2019) -
MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma
por: Zhang, Xudong, et al.
Publicado: (2016)